China NMPA Product Recall - ABO/Rh blood typing retest card (column agglutination method)

Ausendo Medical Devices Trading (China) Co., Ltd. has initiated a voluntary Level II recall of its ABO/Rh Blood Typing Cards (Column Agglutination Method). This action, reported to the National Medical Products Administration (NMPA) and linked to a Shanghai Food and Drug Administration medical device registration, addresses a significant product defect. The primary issue identified is the occurrence of false negative reactions in the anti-D (RH1) reagent when utilized with specific batches of the blood typing cards, particularly batch number ACC054H. Such inaccuracies in blood typing can have serious implications for patient safety, as correct ABO/Rh classification is fundamental for safe blood transfusions and other medical procedures. The recall requires the company to retrieve all affected units of the ABO/Rh Blood Typing Cards from distribution. While the document specifies a voluntary recall, it operates under the regulatory oversight of the NMPA, indicating a structured process for addressing product safety concerns. Further details regarding the precise models, specifications, and complete list of affected batches are contained within an accompanying "Medical Device Recall Event Report Form." This recall emphasizes the critical importance of product reliability in medical diagnostics and the necessity for companies to promptly address and rectify any performance deficiencies to ensure public health.